Ranbaxy to provide generics in Germany under deal with AOK
This article was originally published in Scrip
Executive Summary
Basics, a 100% subsidiary of Ranbaxy Laboratories, is to provide medicines in Germany following an agreement with AOK Baden-Wurttemberg. The agreement, which runs for two years, comes into effect on June 1st and includes Ranbaxy's cefaclor Basics (exclusive for all 15 AOK regional associations and five zones) and tamsulosin Basics (exclusive for 13 AOK regional associations and four zones ,with the exception of AOK Rhineland/Hamburg and AOK Westfalen Lippe zone). AOK is Germany's biggest health insurance group and its subscribers comprise nearly 24 million people.